Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany
· Delayed Price · Currency is EUR 463.30
+8.25 (1.81%)
Feb 21, 2025, 5:35 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €118.98 billion as of February 21, 2025. Its market cap has increased by 19.24% in one year.
Market Cap
118.98B
Enterprise Value
109.91B
Revenue
10.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
€463.30
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 118.98B, an increase of 160,932.32%. That is a compound annual growth rate of 24.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 62.99B |
| Merck KGaA | 58.89B |
| Bayer Aktiengesellschaft | 20.93B |
| Fresenius SE & Co. KGaA | 20.70B |
| Sartorius Aktiengesellschaft | 14.77B |
| Fresenius Medical Care AG | 13.11B |
| Carl Zeiss Meditec AG | 4.85B |
| Fielmann Group AG | 3.54B |